Simple jQuery Dropdowns

Browsing by Author Gilead Sciences Incorporated

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
4-May-2019Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trialsYeon Sook Kim; Shinichi Oka; Ploenchan Chetchotisakd; Amanda Clarke; Khuanchai Supparatpinyo; Anchalee Avihingsanon; Winai Ratanasuwan; Sasisopin Kiertiburanakul; Kiat Ruxrungtham; Sang Youn Yang; Susan Guo; Ya Pei Liu; Moupali Das; Do Tran; Damian McColl; Roberto Corales; Chris Nguyen; David Piontkowsky; National Center for Global Health and Medicine; Chungnam National University; Khon Kaen University; The HIV Netherlands Australia Thailand Research Collaboration; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Brighton and Sussex University Hospitals NHS Trust; Gilead Sciences Incorporated; Chiang Mai University; Thai Red Cross AIDS Research Centre
1-Sep-2004Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1Punnee Pitisuttithum; Phillip W. Berman; Benjaluck Phonrat; Pravan Suntharasamai; Suwanee Raktham; La Ong Srisuwanvilai; Krit Hirunras; Dwip Kitayaporn; Jaranit Kaewkangwal; Sricharoen Migasena; Haynes W. Sheppard; Elizabeth Li; Marlene Chernow; Michael L. Peterson; Riri Shibata; William L. Heyward; Donald P. Francis; Mahidol University; VaxGen, Inc.; Bangkok Metropolitan Administration; Viral Rickettsial Disease Laboratory; Novacea, Inc.; Gilead Sciences Incorporated
1-Feb-2019Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trialLai Wei; Seng Gee Lim; Qing Xie; Kính Nguyen Văn; Teerha Piratvisuth; Yan Huang; Shanming Wu; Ming Xu; Hong Tang; Jun Cheng; Hung Le Manh; Yanhang Gao; Zhuangbo Mou; Abhasnee Sobhonslidsuk; Xiaguang Dou; Satawat Thongsawat; Yuemin Nan; Chee Kiat Tan; Qin Ning; Hoi Poh Tee; Yimin Mao; Luisa M. Stamm; Sophia Lu; Hadas Dvory-Sobol; Hongmei Mo; Diana M. Brainard; Yong Feng Yang; Long Dao; Gui Qiang Wang; Tawesak Tanwandee; Peng Hu; Pisit Tangkijvanich; Lunli Zhang; Zhi Liang Gao; Feng Lin; Thi Tuyet Phuong Le; Jia Shang; Guozhong Gong; Jun Li; Minghua Su; Zhongping Duan; Rosmawati Mohamed; Jin Lin Hou; Jidong Jia; Jinan Infectious Disease Hospital; The First Bethune Hospital of Jilin University; Peking University People's Hospital; Peking University First Hospital; The First Affiliated Hospital of Guangxi Medical University; Beijing YouAn Hospital, Capital Medical University; The Second Hospital of Nanjing; Hainan Provincial People's Hospital; Second Xiangya Hospital of Central-South University; Xiangya Hospital of Central-South University; Shanghai Jiao Tong University School of Medicine; Guangzhou Eighth People's Hospital; Henan Provincial People's Hospital; West China School of Medicine/West China Hospital of Sichuan University; Beijing Friendship Hospital, Capital Medical University; Beijing Ditan Hospital Capital Medical University; Bach Mai Hospital; National University Hospital, Singapore; Songklanagarind Hospital; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; UCL; Sun Yat-Sen University; Chongqing Medical University; Singapore General Hospital; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Maharaj Nakorn Chiang Mai Hospital; University of Malaya Medical Centre; Faculty of Medicine, Siriraj Hospital, Mahidol University; Hebei Medical University; China Medical University Shenyang; Nanchang University; Gilead Sciences Incorporated; Southern Medical University; Tongji Medical College; Shanghai Public Health Clinical Centre; National Hospital for Tropical Diseases; Jiangsu Province People's Hospital; People's Hospital 115; Hospital Tengku Ampuan Afzan